- Home
- EM vs INZY Comparison
EM vs INZY Comparison
Compare EM & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- INZY
- Stock Information
- Founded
- EM 2017
- INZY 2015
- Country
- EM China
- INZY United States
- Employees
- EM N/A
- INZY N/A
- Industry
- EM Other Consumer Services
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- EM Consumer Discretionary
- INZY Health Care
- Exchange
- EM Nasdaq
- INZY Nasdaq
- Market Cap
- EM 191.0M
- INZY 188.2M
- IPO Year
- EM 2021
- INZY 2020
- Fundamental
- Price
- EM $1.10
- INZY $1.34
- Analyst Decision
- EM Strong Buy
- INZY Strong Buy
- Analyst Count
- EM 1
- INZY 8
- Target Price
- EM $1.00
- INZY $17.75
- AVG Volume (30 Days)
- EM 1.7M
- INZY 770.8K
- Earning Date
- EM 01-28-2025
- INZY 03-11-2025
- Dividend Yield
- EM N/A
- INZY N/A
- EPS Growth
- EM N/A
- INZY N/A
- EPS
- EM 0.03
- INZY N/A
- Revenue
- EM $269,745,696.00
- INZY N/A
- Revenue This Year
- EM N/A
- INZY N/A
- Revenue Next Year
- EM $6.16
- INZY N/A
- P/E Ratio
- EM $32.87
- INZY N/A
- Revenue Growth
- EM N/A
- INZY N/A
- 52 Week Low
- EM $0.46
- INZY $1.32
- 52 Week High
- EM $1.18
- INZY $7.80
- Technical
- Relative Strength Index (RSI)
- EM 82.12
- INZY 20.16
- Support Level
- EM $0.68
- INZY $1.32
- Resistance Level
- EM $1.02
- INZY $1.44
- Average True Range (ATR)
- EM 0.04
- INZY 0.25
- MACD
- EM 0.02
- INZY -0.12
- Stochastic Oscillator
- EM 95.00
- INZY 1.61
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.